Arylarnine N-acetyltransferase as a potential biornarker in bladder cancer: fluorescent in situ hybridization and irnmunohistochernistry studies

References

• Anand R., Riley J. H., Smith J. C., Markham A. F. A 3.5 genome equivalent multi-access YAC library: construction, characterisation, creening and storage. Nucleic Acid Research 1990; 18: 1951–1956
   PubMed Web of Science ®Google Scholar
• Bell D. A., Stephens E. A., Castriano T., Umbach D. M., Watson M., Deakin M., Elder J., Henrickse C., Duncan H., Strange R. C. Polyadenylation polymorphism in the acetyltransferase l gene (NAT1increases risk of colorectal cancer. Cancer Research 1995; 55: 3537–3542
   PubMed Web of Science ®Google Scholar
• Blum M., Demierre A., Grant D. M., Heim M., Meyer U. A. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proceedings of The National Academy of Sciences of the USA 1991; 88: 5237–5241
   PubMed Web of Science ®Google Scholar
• Brown T. A. Molecular Biology: Lab fax. Bios Scientific, Oxford 1991; 284
   Google Scholar
• Buckle V. J., Rack K. A. Fluorescence in situ hybridisation. Human Genetic Disease Analysis: A Practical Approach2nd edition, K. E. Davies. Oxford University Press, Oxford 1993; 59–82
   Google Scholar
• Burke D. T., Carle G. F., Olson M. V. Cloning of large segments of exogenous DNA into yeast by means of artificial chromosome vectors. Science 1987; 236: 806–812
   PubMed Web of Science ®Google Scholar
• Cartwright R. A., Glashan R. W., Rogers H. J., Ahmad R. A., Barham-Hall D., Higgins E., Kahn M. A. Role ofN-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 1982; 2: 842–846
   PubMed Web of Science ®Google Scholar
• Coroneos E., Sim E. ArylamineN-acetyltransferase activity in human cultured cell lines. Biochemical Journal 1993; 294: 481–486
   PubMed Web of Science ®Google Scholar
• Coroneos E., Gordon J. W., Kelly S. L., Wang P. D., Sim E. Drug metabolisingN-acetyltransferase activity in human cell lines. Biochimica et Biophysica Acta 1991; 1073: 593–599
   PubMed Web of Science ®Google Scholar
• Cribb A. E., Grant D. M., Miller M. A., Spielberg S. P. Expression of monomorphic arylamineN-acetyltransferase (NAT1in human eucocytes. Journal of Pharmacology and Experimental Therapeutics 1991; 259: 1241–1246
   PubMed Web of Science ®Google Scholar
• Cribb A. E., Nakamura H., Grant D. M., Miller M. A., Spielberg S. P. Role of polymorphic and monomorphic human arylamine -acetyltransferases in determining sulphamethoxazole metabolism. Biochemical Pharmacology 1993; 45: 1277–1282
   PubMed Web of Science ®Google Scholar
• Deguchi T. Sequences and expression of alleles of polymorphic arylamineN-acetyltransferase of human liver. Journal of Biological Chemistry 1992; 267: 18140–18147
   PubMed Web of Science ®Google Scholar
• Franke S., Klawitz I., Schnakenberg E., Rommel B., Van DE Ven W., Buller Oiek J., Schloot W. Isolation and mapping of a cosmid clone containing the humanNAT2 gene. Biochemical and Biophysical 1994; 199: 52–55, Research Communications
   PubMed Web of Science ®Google Scholar
• Fujiwara Y., Ohata H., Kuroki T., Koyama K., Tsuchiya E., Monden M., Nakamura Y. Isolation of a candidate turnour suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain on the PDGF receptor beta gene. Oncogene 1995; 10: 891–895
   PubMed Web of Science ®Google Scholar
• Govier W. C. Reticuloendothelial cells as the site of sulfanilamide acetylation in the rabbit. Journal of Pharmacology and Experimental Therapeutics 1965; 150: 305–308
   PubMed Web of Science ®Google Scholar
• Grant D. M. Molecular genetics of Nacetyltransferases. Pharmacogenetics 1993; 3: 45–50
   PubMedGoogle Scholar
• Hayes R. B., Bi W., Rothman N., Broly F., Caporaso N., Feng P., You X., Yin S., Woosley R. L., Meyer U. A. N-Acetylation phenotype and genotype and risk of bladder cancer in benzidineexposed workers. Carcinogenesis 1993; 14: 675–678
   PubMed Web of Science ®Google Scholar
• Hein D. W., Doll M. A., Rustan T. D., Gray K., Feng Y., Ferguson R. J., Grant D. M. Metabolic activation and deactivation of arylamine carcinogens by recombinant NAT1 and polymorphic NAT2 acetyitransferases. Carcinogenesis 1993; 14: 1633–1638
   PubMed Web of Science ®Google Scholar
• Hein D. W., Rustan I D., Ferguson R. J., Doll M. A., Gray K. Metabolic activation of aromatic and heterocyclicN-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Archives of Toxicology 1994; 68: 129–133
   PubMed Web of Science ®Google Scholar
• Hickman D., Risch A., Buckle V., Spurr N. K., Sim E. Chromosomal localization of human genes for arylamineN-acetyltransferase. Biochemical Journal 1994; 297: 441–445
   PubMed Web of Science ®Google Scholar
• Hickman D., Risch A., Camilleri J. P., Sim E. Genotyping human polymorphic arylamineN-acetyltransferase identification of new slow allotypic variants. Pharmacogenetics 1992; 2: 217–226
   PubMedGoogle Scholar
• Kloth M. T., Gee R. L., Messng E. M., Swamina Man S. Expression ofN-acetyltransferase (NATI in cultured human urothoepithelial cells. Carcinogenesis 1994; 15: 2781–2787
   PubMed Web of Science ®Google Scholar
• Knowles M. A., Shaw M. E., Proctor A. J. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene 1993; 8: 1357–1364
   PubMed Web of Science ®Google Scholar
• McPartlin J., Halligan A., Scott J. M., Darling M., Weir D. G. Accelerated folate breakdown in pregnancy. Lancet 1993; 341: 148–149
   PubMed Web of Science ®Google Scholar
• McQueen C. A., Weer W. W. Characterization of human lymphocyteN-acetykransferase and its relationship to the isoniazid acetylator polymorphism. Biochemical Genetics 1980; 18: 889–903
   PubMed Web of Science ®Google Scholar
• Mendez M., Erickson P., Scott P., Drabkin H. A., Gemmill R. M. Isolation of YAC clones from genomic libraries by southern blot hybridization. YAC libraries. A User's Guide, D. L. Nelson, B. H. Brownstein. W. H. Freeman and Company, New York 1994; 57–91
   Google Scholar
• Minchin R. F. Acetylating of para-aminobenzoylglutamate, a float actability, by recombinantN-acetyltransferase and U937 cells. Biochemical Journal 1995; 307: 1–3
   PubMed Web of Science ®Google Scholar
• Ohsako S., Deguchi T. Cloning and expression of cDNAs for polymorphic and monomorphic arylamineN-acetyltransferases from human liver. Journal of Biological Chemistry 1990; 265: 4630–4634
   PubMed Web of Science ®Google Scholar
• Pacifici G. M., Bencini C., Rane A. Acetyltransferase in humans: development and tissue distribution. Pharmacology 1986; 32: 283–291
   PubMed Web of Science ®Google Scholar
• Price-Evans D. A., Manly K. A., McKussick V. A. Genetic control of isoniazid metabolism in man. British Medical Journal 1960; 2: 485–491
   PubMed Web of Science ®Google Scholar
• Rehn L. Blasengeschwuelste bei Fuchsin-Arbeitern. Archive der Klinischen Chirurgie 1895; 50: 588–600
   Google Scholar
• Reid T, Lenguar C., Cremer T., Wiegant J., H A. K., Ploeg M. V., Grom P., Lipp M. Specific metaphase and interphase detection of the breakpoint region in 8q24 of Burkitt Lymphoma cells by triple colour fluorescencein situ hybridisation. Genes. Chromosomes and Cancer 1992; 4: 69–74
   PubMed Web of Science ®Google Scholar
• Risch A., Wallace D. M. A., Bathers S., Sim E. Slow Nacetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Human. Molecular Genetics 1995; 4: 231–236
   PubMed Web of Science ®Google Scholar
• Sandberg A. A. Chromosome changes in early bladder neoplasms. Journal of Cellular Biochemistry 1992; 161: 76–79, Suppl.
   Google Scholar
• Sandberg A. A., Berger C. S. Review of chromosome studies in urological tumours II. Cytogenetics and molecular genetics of bladder cancer. Journal of Urology 1994; 151: 545–560
   PubMed Web of Science ®Google Scholar
• Smih G., Stanley L. A., Sm E., Saw R. C., Wolf C. R. Metabolic olymorphism and cancer susceptibility. Cancer Surveys 1995; 25: 27–65
   PubMedGoogle Scholar
• Spurr N. K., Wlanton S., Bookstein R. C., Iarke R., Comgtw R., Daiger S., Drayna D., Faber P., Horrigan S., Kas K., Kirchgessner C., Kumar S., Leach R. J., Luedecke H.-J., Nakamura Y., Pebusque M.-J., Ranta S., Sim E., Sullivan L. S., Takle L., Vance J., Wagner M., Wells D., Westbrook C., Yaremko L., Zaletayev D., ZuffarOi O., Wooo S. Report of the second international workshop on human chromosome 8 mapping 1994. Cytogenics and Cell Genetics 1995; 68: 147–164
   PubMedGoogle Scholar
• Stacey M., Bennett M. S., Hulten M. FISH analysis of spontaneously arising micronuclei in the ICF syndrome. Journal of Medical Genetics 1995; 32: 502–508
   PubMed Web of Science ®Google Scholar
• Stanley L. A., Coroneos E., Cuff R., Hickman D., Ward A., Sim E. ArylamineN-acetyltransferase expression in human bladder cells: an immunochemical study. Biochemical Journal 1996, in press
   Google Scholar
• Stock C., Ambros I. M., Lion I., Haas O. A., Zoubek A., Ambros P. F. Detection of numerical and structural chromosome abnormalities in paediatric germ cell tumours by means of interphase cytogenetics. Genes, Chromosomes and. Cancer 1994; 11: 40–50
   Web of Science ®Google Scholar
• Turesky R. J., Lang N. P., Butler M. A., Teitel C., Kadlubar F. F. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 1991; 12: 1839–1844
   PubMed Web of Science ®Google Scholar
• Vatsis K. P., Weber W. W., Bell D. A., Dupret J.-M., Price-Evans D. A., Grant D. M., Hein D. W., Lin H. J., Meyer U. A., Relling M. V., Sim E., Suzuki T., Yamazoe Y. Nomenclature forN-acetyltransferases. Harmacogenetics 1995; 5: 1–17
   PubMedGoogle Scholar
• Vineis P., Bartsch H., Caporaso N., Harrington A. M., Kadlubar F. F., Landi M. T., Malaveille C., Shields P. G., Skipper P., Talaska G., Tannenbaum S. R. Genetically basedN-acetyltransferase metabolic polymorphism and low level environmental exposure to carcinogens. Nature 1994; 369: 154–156
   PubMed Web of Science ®Google Scholar
• Ward A., Hickman D., Gordon J., Sim E. ArylamineN acetyltransferase in human red blood cells. Biochemical Pharmacology 1992; 44: 1099–1104
   PubMed Web of Science ®Google Scholar
• Ward A., Summers M. J., Su E. Purification of recombinant humanN-acetyltransferase type 1 (NATlexpressed inE. coli and characterization of its potential role in folate metabolism. Biochemical Pharmacology 1995; 49: 1759–1767
   PubMed Web of Science ®Google Scholar
• Weber W. W., Vatsis K. P. Individual variability inp-aminobenzoic acid Nacetylation by humanN-acetyltransferase (NAT1of peripheral blood. Pharmacokinetics 1993; 3: 209–212
   Google Scholar
• Wild D. W., Fester W., Michel S., Lord H. L., Josephy P. D. Metabolic activation of heterocyclic aromatic amines catalyzed by human arylamineN-acetyltransferase isozymes (NAT1 and NAT2expressed in. Salmonella typhimurium. Carcinogenesis 1995; 16: 643–648
   Google Scholar
• Wood S., Schertzer M., Drabkin H., Paterson D., Longmire J. L., Deaven L. L. Characterization of a human chromosome 8 cosmid library constructed from flowsorted chromosomes. Cytogenetics and. Cell Genetics 1992; 59: 243–247
   PubMed Web of Science ®Google Scholar